HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Body Weight (Weight, Body)

The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Also Known As:
Weight, Body; Body Weights; Weights, Body
Networked: 130203 relevant articles (7141 outcomes, 11293 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Insulin Resistance
2. Obesity
3. Neoplasms (Cancer)
4. Inflammation (Inflammations)
5. Type 2 Diabetes Mellitus (MODY)

Experts

1. Wang, Jing: 107 articles (09/2022 - 09/2007)
2. Zhang, Wei: 98 articles (08/2022 - 06/2002)
3. Liu, Yi: 90 articles (08/2022 - 10/2005)
4. Wang, Wei: 89 articles (05/2022 - 07/2003)
5. Flatt, Peter R: 86 articles (08/2022 - 09/2004)
6. Zhang, Li: 85 articles (02/2022 - 01/2003)
7. Seeley, Randy J: 84 articles (01/2021 - 06/2002)
8. Mortensen, Alicja: 83 articles (07/2022 - 04/2012)
9. Crebelli, Riccardo: 81 articles (07/2022 - 05/2017)
10. Zhang, Yan: 80 articles (08/2022 - 11/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Body Weight:
1. Glucose (Dextrose)FDA LinkGeneric
2. LipidsIBA
04/12/2023 - "According to the experimental results, PPPs were most effective in reducing the body weight and serum and liver lipid levels. "
04/21/2005 - "Compared with the NASH group, there were no significant changes in body weight, liver weight, blood biochemical index, the degree of hepatic steatosis, and histological activity index (HAI) score in the UDCA group; however, body and liver weights were significantly decreased, and the degree of steatosis was markedly improved in rats of both the LCD group and the UDCA+LCD group, but significant improvement with regard to serum lipid variables and hepatic inflammatory changes were seen only in rats of the UDCA+LCD group, and not in the LCD group. "
09/01/2021 - "In in vivo studies, LBPs significantly inhibited body weight gain, reduced lipid levels in serum and liver, and improved oxidative damage in a dose-dependent manner in mice fed a high-fat diet. "
01/25/2014 - "CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models."
12/01/2012 - "After the 12-week study, the Doenjang supplementation group had significant reductions in body weight (kg), body fat mass (kg) and body fat (%) compared to the placebo group, the supplementation of Doenjang resulted in a significant reduction in visceral fat (cm(2)), although no changes were observed in total and subcutaneous fat are as (cm(2)), serum lipid profiles and dietary intakes. "
3. Insulin (Novolin)FDA Link
4. Blood Glucose (Blood Sugar)IBA
5. Triglycerides (Triacylglycerol)IBA
6. Proteins (Proteins, Gene)FDA Link
7. CholesterolIBA
8. CreatinineIBA
08/13/2023 - "A one-compartment model best described the observed data with a mean clearance of 0.11 ± 0.03 L/kg/h and volume of distribution (V) of 1.02 ± 0.08 L/kg. Body weight (WT), postmenstrual age (PMA), and serum creatinine (SCr) were significant covariates associated with clearance (p < 0.001) and body WT was a significant covariate associated with V (p = 0.009). "
11/01/2020 - "Patients who underwent CA were significantly younger (78.9 years vs 81.7 years; p < 0.0001), had significantly greater height and body weight, as well as creatinine clearance rate (CCr) compared with those who did not undergo CA. In both the CA and No-CA groups, the most common type of AF was paroxysmal AF (72.9% and 38.9%). "
11/01/2011 - "The most popular recommended formulas are the simple Cockcroft-Gault equation, which is inaccurate and biased, as it calculates clearance of creatinine in proportion to body weight, and the MDRD equation, which is more accurate, but systematically underestimates normal and high GFR, being established by a statistical analysis of results from renal-insufficient patients. "
05/01/1987 - "Measured CLcr values ranged from 29.8 to 197 mL/min in group 1 and from 2.8 to 118 mL/min in group 2. Ranges of SCr values were 0.7-1.5 mg/dL (mean, 1.1) in group 1 and 1.6-7.1 mg/dL (mean, 2.8) in group 2; the formula of Cockcroft and Gault, which uses age, body weight, and SCr, had the highest correlation and the greatest accuracy in group 1, whereas the formula of Jelliffe, which uses body surface area and SCr, had the highest correlation and the greatest accuracy in group 2. Estimation of creatinine clearance can be improved by identification and use of the formula that is best suited to a specific patient population."
03/31/1998 - "The loss of body weight was accompanied by a marked decrease in plasma creatinine. "
9. LeptinIBA
10. AntioxidantsIBA

Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Oral Administration
4. Aftercare (After-Treatment)
5. Bariatric Surgery